Gene: Ripor1 (RHO family interacting cell polarization regulator 1) Rattus norvegicus
Analyze
Symbol: Ripor1
Name: RHO family interacting cell polarization regulator 1
Description: Predicted to have 14-3-3 protein binding activity; predicted to be involved in several processes, including Rho protein signal transduction, cellular response to chemokine, and cellular response to starvation; predicted to localize to the Golgi apparatus, cell leading edge, and membrane; orthologous to human RIPOR1 (RHO family interacting cell polarization regulator 1); INTERACTS WITH bisphenol A; C60 fullerene; decabromodiphenyl ether.
Type: protein-coding
RefSeq Status: VALIDATED
Also known as: Fam65a; family with sequence similarity 65, member A; hypothetical protein LOC291974; LOC291974; RGD1307772; rho family-interacting cell polarization regulator 1; similar to mKIAA1930 protein
Orthologs:
Latest Assembly: Rnor_6.0 - RGSC Genome Assembly v6.0
Position:
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
Rnor_6.01937,555,940 - 37,584,842 (+)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_5.01948,424,412 - 48,452,711 (+)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.41935,438,485 - 35,446,556 (+)NCBIRGSC3.4rn4RGSC3.4
RGSC_v3.11935,443,365 - 35,451,436 (+)NCBI
Celera1932,917,984 - 32,934,712 (+)NCBICelera
Cytogenetic Map19q12NCBI
JBrowse: View Region in Genome Browser (JBrowse)
Model


Gene-Chemical Interaction Annotations
Gene Ontology Annotations
References - curated
References - uncurated

Genomics

Comparative Map Data
Position Markers
QTLs in Region (Rnor_6.0)
miRNA Target Status

Sequence

Nucleotide Sequences
Protein Sequences
Transcriptome
Promoters

Strain Variation

Strain Sequence Variants (Rnor 5.0)
Damaging Variants

Additional Information

External Database Links
Nomenclature History
 
More on Ripor1
Alliance Gene
NCBI Gene
Ensembl Gene
JBrowse: rn5 rn6
NCBI Genome Data Viewer

CRRD Object Information
CRRD ID: 1307772
Created: 2005-01-12
Species: Rattus norvegicus
Last Modified: 2019-04-23
Status: ACTIVE



NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.